Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles
- 15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
At AstraZeneca, we are driven by science and united by our commitment to deliver life-changing medicines to patients. With one of the industry's most diverse and successful portfolios spanning multiple therapeutic areas and modalities, we offer a unique opportunity to contribute to drug development from early discovery through to post-marketing support.
We are seeking an experienced Senior Reproductive Toxicologist to join our d evelopmental and r eproductive t oxicology team within Regulatory Toxicology and Safety Pharmacology, part of Clinical Pharmacology and Safety Sciences (CPSS). This is a role for an individual who combines deep reproductive toxicology expertise with the ability to influence multidisciplinary teams and contribute strategically to drug development programmes.
Working across a broad portfolio, you will help shape development plans, support regulatory submissions and health authority interactions, guide product labelling strategies, and ensure reproductive safety considerations are appropriately integrated throughout the development lifecycle.
The role will ideally be based at one of AstraZeneca's major US R&D sites in Gaithersburg or Boston (USA) , however o ther AstraZeneca strategic R&D locations may be considered for exceptional candidates.
What you'll do
As a Senior Reproductive Toxicologist, you will provide expert scientific leadership and strategic guidance across AstraZeneca's portfolio, supporting programmes ranging from discovery through late-stage development, registration, and post-marketing activities.
Key responsibilities include:
• Providing expert interpretation of developmental, reproductive and juvenile toxicology data and translating findings into development and regulatory strategy.
• Partnering with multidisciplinary project teams to support clinical development plans, regulatory submissions, health authority interactions and product labelling.
• Advising on reproductive safety assessments, inclusion of women of childbearing potential and paediatric populations in clinical development programmes.
• Designing and overseeing reproductive toxicology programmes that support global development and registration strategies across multiple therapeutic areas and modalities.
• Contributing to governance discussions and presenting reproductive toxicology positions to project teams.
• Supporting interactions with global regulatory agencies and contributing to responses to regulatory questions.
• Representing AstraZeneca in external scientific forums, industry collaborations and consortia related to reproductive toxicology and paediatric development.
• Contributing to the continued evolution of AstraZeneca's reproductive toxicology strategy, including innovative approaches that advance science and reduce animal usage.
Minimum Qualifications:
We are looking for an experienced reproductive toxicologist with strong scientific judgement, strategic thinking and the ability to influence across multidisciplinary teams.
You will bring:
• Bachelor's degree in a related field.
• Industry experience applying developmental and reproductive toxicology expertise , including experience supporting one or more of: marketing applications, health authority interactions, regulatory submissions or product labelling. Typically gained through 5+ years of relevant experience.
• Demonstrated experience supporting late-stage clinical development, marketing applications, product labelling and post-marketing activities.
• Strong knowledge and practical application of relevant global regulatory guidelines, including ICH M3, S5, S6, S9 and S11.
• Experience supporting health authority interactions and regulatory submissions across global regions (EMA, PMDA, CDE and FDA)
Apply on employer site ↗